Source: cdc.gov
Notes: In the chart above, comparable countries include Australia, Austria, Belgium, Canada, France, Germany, Japan, the Netherlands, Sweden, Switzerland, and the U.K. 2023 U.K. life expectancy data is only for England and Wales
Source: cdc.gov
Note: 2020-2023 represents a 3-year change.
Source: cdc.gov
Notes: Public insurance in 1970 includes Department of Veterans Affairs, Department of Defense. Medicare, and Medicaid. In 2023, public insurance includes the same categories listed for 1970, with the addition of CHIP. “Other” includes spending on public health activities, investment, and third party payers and programs like worksite health care, the Indian Health Service, and other state and local programs.
| Drug Name | Clinical use(s) | List price, 2024 | Big Four price, 2024 | Medicare negotiated price, 2026 |
|---|---|---|---|---|
| Eliquis | Blood thinner | $594 | $402 | $249 |
| Jardiance | Diabetes, Heart failure | $611 | $434 | $204 |
| Xarelto | Blood thinner | $542 | $392 | $206 |
| Farxiga | Diabetes, Heart failure | $582 | $420 | $182 |
| Januvia | Diabetes | $547 | $392 | $117 |
| Entresto | Heart failure | $668 | $478 | $314 |
| Enbrel | Psoriasis, Rheumatoid arthritis | $7,402 | $4,775 | $2,335 |
| Imbruvica | Blood cancers | $17,018 | $10,669 | $10,619 |
| Stelara | Crohn’s disease, Psoriasis | $26,517 | $9,472 | $4,490 |
| NovoLog/Fiasp | Diabetes | $140 | $138 | $134 |
Source: US Dept. of Veterans Affairs, CMS
Note: List prices are as of January 2024 and were collected from the Texas State Department of Health Services Prescription Drug Price Disclosure Program. “Big Four” prices were collected from the VA National Acquisition Center website. All drug prices correspond to the NDC-11 codes shown in the Appendix and are calculated for a 30-day supply as described in the Methods. The list price for NovoLog was significantly reduced by Novo Nordisk, Inc after NovoLog was selected for price negotiation.
| Country | Eliquis | Jardiance | Xarelto | Farxiga | Januvia | Entresto | Enbrel | Imbruvica |
|---|---|---|---|---|---|---|---|---|
| 🇺🇸 U.S. - Medicare | ||||||||
| Comparable Country Average | ||||||||
| 🇨🇭 Switzerland | ||||||||
| 🇩🇪 Germany | ||||||||
| 🇧🇪 Belgium | ||||||||
| 🇦🇹 Austria | ||||||||
| 🇯🇵 Japan | ||||||||
| 🇳🇱 Netherlands | ||||||||
| 🇬🇧 United Kingdom | ||||||||
| 🇨🇦 Canada | ||||||||
| 🇫🇷 France | ||||||||
| 🇸🇪 Sweden | ||||||||
| 🇦🇺 Australia |
Source: KFF
Note: Prices were converted to $USD using exchange rates as of June 30, 2024 and are rounded to the nearest dollar. Prices are for a 30-day supply (see Methods section for dosage and frequencies used). Medicare and Big Four prices shown are based on NDC-11 codes corresponding to the specific dosages described in the Methods.
Elevating healthcare solutions through research and innovation on a global scale.